PSMA PET-CT redefines nonmetastatic castration-resistant prostate cancer.,Nature Reviews Urology

当前位置： X-MOL 学术 › Nat. Rev. Urol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

PSMA PET-CT redefines nonmetastatic castration-resistant prostate cancer.
Nature Reviews Urology ( IF 12.1 ) Pub Date : 2019-12-09 , DOI: 10.1038/s41585-019-0268-1
Piet Ost ₁

Affiliation

New data show that prostate-specific membrane antigen (PSMA) PET–CT can reveal the anatomical location of prostate cancer recurrences in patients diagnosed with nonmetastatic castration-resistant disease according to conventional imaging. The findings necessitate a new evaluation of the role of PSMA PET–CT in this setting compared with standard-of-care imaging and treatment approaches.

中文翻译：

PSMA PET-CT重新定义了非转移性去势抵抗性前列腺癌。

新数据表明，根据常规成像，前列腺特异性膜抗原（PSMA）PET-CT可以揭示诊断为非转移性去势抵抗性疾病的患者前列腺癌复发的解剖位置。这些发现需要对PSMA PET-CT在这种情况下与照护标准成像和治疗方法相比的作用进行新的评估。

更新日期：2019-12-09

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11